TGF-β-mediated suppression by CD4+CD25+ T cells is facilitated by CTLA-4 signaling

被引:111
作者
Oida, Takatoku
Xu, Lili
Weiner, Howard L.
Kitahi, Atsushi
Strober, Warren
机构
[1] NIAID, Mucosal Immun Sect, Clin Invest Lab, NIH,Clin Res Ctr, Bethesda, MD 20892 USA
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA
关键词
D O I
10.4049/jimmunol.177.4.2331
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD4(+)CD25(+) T cells play a pivotal role in immunological homeostasis by their capacity to exert immunosuppressive activity. However, the mechanism by which these cells function is still a subject for debate. We previously reported that surface (membrane) TGF-beta produced by CD4(+)CD25(+) T cells was an effector molecule mediating suppressor function. We now support this finding by imaging surface TGF-beta on Foxp3(+)CD4(+)CD25(+) T cells in confocal fluorescence microscopy. Then, using a TGF-beta-sensitive mink lung epithelial cell (luciferase) reporter system, we show that surface TGF-beta can be activated to signal upon cell-cell contact. Moreover, if such TGF-beta signaling is blocked in an in vitro assay of CD4(+)CD25(+) T cell suppression by a specific inhibitor of TGF-beta RI, suppressor function is also blocked. Finally, we address the role of CTLA-4 in CD4(+)CD25(+) T cell suppression, showing first that whereas anti-CTLA-4 does not block in vitro suppressor function, it does complement the blocking activity of anti-TGF-beta. We then show with confocal fluorescence microscopy that incubation of CD4(+)CD25(+) T cells with anti-CTLA-4- and rB7-1/Fc-coated beads results in accumulation of TGF-beta at the cell-bead contact site. This suggests that CTLA-4 signaling facilitates TGF-beta-mediated suppression by intensifying the TGF-beta signal at the point of suppressor cell-target cell interaction.
引用
收藏
页码:2331 / 2339
页数:9
相关论文
共 39 条
[31]   Structural basis for co-stimulation by the human CTLA-4/B7-2 complex [J].
Schwartz, JCD ;
Zhang, XW ;
Fedorov, AA ;
Nathenson, SG ;
Almo, SC .
NATURE, 2001, 410 (6828) :604-608
[32]   Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses [J].
Stamper, CC ;
Zhang, Y ;
Tobin, JF ;
Erbe, DV ;
Ikemizu, S ;
Davis, SJ ;
Stahl, ML ;
Seehra, J ;
Somers, WS ;
Mosyak, L .
NATURE, 2001, 410 (6828) :608-611
[33]   Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells:: induction of autoimmune disease by breaking their anergic/suppressive state [J].
Takahashi, T ;
Kuniyasu, Y ;
Toda, M ;
Sakaguchi, N ;
Itoh, M ;
Iwata, M ;
Shimizu, J ;
Sakaguchi, S .
INTERNATIONAL IMMUNOLOGY, 1998, 10 (12) :1969-1980
[34]   Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4 [J].
Takahashi, T ;
Tagami, T ;
Yamazaki, S ;
Uede, T ;
Shimizu, J ;
Sakaguchi, N ;
Mak, TW ;
Sakaguchi, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (02) :303-309
[35]   Distinct robes of CTLA-4 and TGF-β in CD4+CD25+ regulatory T cell function [J].
Tang, QZ ;
Boden, EK ;
Henriksen, KJ ;
Bour-Jordan, H ;
Bi, MY ;
Bluestone, JA .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (11) :2996-3005
[36]   Furin at the cutting edge: From protein traffic to embryogenesis and disease [J].
Thomas, G .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2002, 3 (10) :753-766
[37]   CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production [J].
Thornton, AM ;
Shevach, EM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (02) :287-296
[38]   Human T cell activation by costimulatory signal-deficient allogeneic cells induces inducible costimulator-expressing anergic T cells with regulatory cell activity [J].
Vermeiren, J ;
Ceuppens, JL ;
Van Ghelue, M ;
Witters, P ;
Bullens, D ;
Mages, HW ;
Kroczek, RA ;
Van Gool, SW .
JOURNAL OF IMMUNOLOGY, 2004, 172 (09) :5371-5378
[39]   Activation of CD25+CD4+ regulatory T cells by oral antigen administration [J].
Zhang, XM ;
Izikson, L ;
Liu, LM ;
Weiner, HL .
JOURNAL OF IMMUNOLOGY, 2001, 167 (08) :4245-4253